- High efficiency due to synergy of active ingredients
- Maximum result of colibacillosis therapy
1.0 ml of the drug contains 100.0 mg of enrofloxacin, 50.0 mg of colistin sulfate and excipients (lactic acid, propylene glycol, benzyl alcohol, distilled water) – up to 1.0 ml as active ingredients.
It is used as a therapeutic and prophylactic agent for colibacillosis, salmonellosis, pasteurellosis, mycoplasmosis, infectious synovitis, bordetelliosis, infectious rhinitis, staphypococcosis and other infectious diseases caused by microorganisms sensitive to the components of the drug in poultry.
The drug is produced in polymer containers of 100.0, 500.0 and 1000.0 ml.